ArriVent BioPharma has dosed the first patient in a U.S. Phase 1 trial of ARR-002, a novel tetravalent antibody-drug conjugate targeting MUC16 and NaPi2b for ovarian and endometrial cancers. This dual-target approach aims to improve treatment effectiveness by addressing tumor heterogeneity, potentially overcoming limitations of single-target therapies. The company also secured exclusive rights to develop and commercialize ARR-002 in Greater China. The trial will assess safety, tolerability, efficacy, and pharmacokinetics, marking a significant step in ArriVent's expanding oncology pipeline.
ArriVent's announcement of dosing the first patient with ARR-002 is presented here with Pluang's Health sector market data as of Oct 13, 2026 02:02 WIB. Among 128 priced Health-sector US stocks tradable on Pluang, 62 advanced while 65 declined. Notable movers include DNA (Ginkgo Bioworks Holdings Inc) at USD 11.67, down 10.23%, CGC (Canopy Growth Corp) at USD 0.75, down 9.58%, and BNGO (BioNano Genomics Inc) at USD 1.30, down 9.06%.
Pepeto, a new Ethereum-based cryptocurrency, has launched its page on CoinMarketCap, indicating a Binance listing is near. The project features a working bridge across Ethereum, BNB Chain, and Solana, with zero-cost token transfers and AI contract ch...
Crédit Agricole has signed an agreement to acquire 100% of IKB Deutsche Industriebank, a key financial partner for Germany's Mittelstand companies. This acquisition aligns with Crédit Agricole's ACT 2028 strategic plan to expand in Europe, particular...
Crédit Agricole has signed an agreement to acquire 100% of IKB Deutsche Industriebank, a key financier for Germany's Mittelstand companies. This acquisition strengthens Crédit Agricole's expansion in Germany, Europe's largest economy, aligning with i...
The complicated urinary tract infections (cUTI) market is projected to expand steadily through 2036, driven by increasing antimicrobial resistance, higher rates of recurrent and hospital-acquired infections, and more patients with underlying conditio...
Integrated Power Services (IPS) has acquired Bold Renewables, the exclusive OEM provider of parts and field services for Advanced Energy solar inverters. This acquisition strengthens IPS's renewable energy platform by adding specialized inverter life...
